OpenAI is rolling out an early version of an artificial intelligence model designed to accelerate drug discovery, joining a ...

This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical ...

AWS's new AI platform grants researchers direct access to a broad library of biological foundation models for lab-in-the-loop drug discovery.

AWS announced the launch of its AI bio tool, Amazon Bio Discovery, to accelerate the early-stage process of drug discovery.

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma. Biotech uses AI for breakthrough discovery, while large pharma scales it to ...

Nvidia is no longer content to be the chip supplier behind other companies’ biotech ambitions. With a multibillion dollar slate of commitments, the company is moving directly into the heart of AI drug ...

Advancing proprietary AI discovery of high-bioavailability Oral GLP-1 drug candidates. HOUSTON, Feb. 3, 2026 /PRNewswire/ -- Deep EigenMatics, Inc., a pioneer in high-velocity Artificial Intelligence ...

NVIDIA (NVDA) and Lilly bring together a world-leading, multidisciplinary team of scientists, AI researchers and engineers to address the hardest problems in drug discovery. The co-innovation lab ...

Forbes contributors publish independent expert analyses and insights. Anisha Sircar is a journalist covering tech, finance and society. This voice experience is generated by AI. Learn more. This voice ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Modern Medical Research Laboratory. Scientific Lab, Drug Engineering Center Full of ...